Dr. Marina Caskey's lab at Rockefeller University focuses on understanding and combating viral infections, particularly HIV and hepatitis B virus (HBV). The lab conducts innovative research to investigate how HIV escapes treatments with broadly neutralizing antibodies (bNAbs) and explores new therapeutic strategies for chronic HBV infection. The goal is to improve immune responses and develop effective treatments that can lead to long-term remission of these viral infections.

Michael P Rout's lab at Rockefeller University focuses on innovative solutions to combat viral pandemics and understand important cellular structures called nuclear pore complexes. They develop advanced nanobodies from llamas to neutralize and treat infections caused by dangerous viruses like SARS-CoV-2, enhancing our preparedness for future outbreaks. Additionally, the lab investigates the structure and function of nuclear pore complexes to better understand their critical roles in gene regulation and cell function, aiming to uncover potential therapeutic targets for various diseases.